Robust neuroprotective effects of 2-((2-oxopropanoyl)oxy)-4-(trifluoromethyl)benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kim, Seung Woo ^a   Lee, Hye Kyung ^a   Kim, Il Doo ^a   Lee, Hahnbie ^a   Luo, Lidan ^a   Park, Ju Young ^b   Yoon, Sung Hwa ^b   Lee, Ja Kyeong ^a  

^a Inha University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4-TRIFLUOROMETHYLSALICYLIC ACID; BENZOIC ACID DERIVATIVE; CYTOKINE; NEUROPROTECTIVE AGENT; SALICYLIC ACID DERIVATIVE;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHEMISTRY; DISEASE MODEL; HYDROLYSIS; IMMUNOLOGY; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALS; BENZOATES; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CYTOKINES; DISEASE MODELS, ANIMAL; HYDROLYSIS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SALICYLATES; STROKE;

EID: 84983261263     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31843     Document Type: Article

References (38)

1. Lipton, S. A. Ischemic cell death in brain neurons. Physiol Rev 79, 1431-1568 (1999).
2. Graham, S. H. & Chen, J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 21, 99-109 (2001).
3. Wu, H. Y. et al. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke. Eur J Pharmacol 740, 522-531 (2014).
4. Fan, X., Lo, E. H. & Wang, X. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats. Stroke 44, 745-752 (2013).
5. Kim, S. W. et al. Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain. Neurotox Res 17, 39-49 (2010).
6. Kim, S. W. et al. Robust protective effects of a novel multimodal neuroprotectant oxopropanoyloxy benzoic acid (a salicylic acid/ pyruvate ester) in the postischemic brain. Mol Pharmacol 79, 220-228 (2011).
7. Bayón, Y., Alonso, A. & Sánchez Crespo, M. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy- 4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation. Br J Pharmacol 126, 1359-1366 (1999).
8. Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J. & Vane, J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90, 11693-11697 (1993).
9. Alvarez-Sabín, J., Quintana, M., Santamarina, E. & Maisterra, O. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up. Cerebrovasc Dis 37, 181-187 (2014).
10. Coma, M. et al. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 38, 482-491 (2010).
11. Fernández de Arriba, A. et al. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Mol Pharmacol 55, 753-760 (1999).
12. Acarin, L., González, B. & Castellano, B. Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage. Stroke 33, 2499-2505 (2002).
13. Sheline, C. T., Behrens, M. M. & Choi, D. W. Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+ ) and inhibition of glycolysis. J Neurosci 20, 3139-3146 (2000).
14. Sharma, P., Karian, J., Sharma, S., Liu, S. & Mongan, P. D. Pyruvate ameliorates post ischemic injury of rat astrocytes and protects them against PARP mediated cell death. Brain Res 992, 104-113 (2003).
15. Yi, J. S., Kim, T. Y., Kyu Kim, D. & Koh, J. Y. Systemic pyruvate administration markedly reduces infarcts and motor deficits in rat models of transient and permanent focal cerebral ischemia. Neurobiol Dis 26, 94-104 (2007).
16. Wang, Q. et al. Pyruvate protects against experimental stroke via an anti-inflammatory mechanism. Neurobiol Dis 36, 223-231 (2009).
17. Imai, Y., Ibata I., Ito, D., Ohsawa, K. & Kohsaka, S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 224, 855-862 (1996).
18. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C. & Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27, 2596-2605 (2007).
19. Pieper, A. A. et al. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc Natl Acad Sci USA 97, 1845-1850 (2000).
20. Wang, Q., Tang, X. N. & Yenari, M. A. The inflammatory response in stroke. J Neuroimmunol 184, 53-68 (2007).
21. Boje, K. M. & Arora, P. K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587, 250-256 (1992).
22. Giulian, D. Immune responses and dementia. Ann N Y Acad Sci 835, 91-110 (1997).
23. Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T. & Koistinaho, J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95, 15769-15774 (1998).
24. Smith, J. A., Das, A., Ray, S. K. & Banik, N. L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87, 10-20 (2012).
25. Ramis, J., Mis, R., Forn, J., Torrent, J., Gorina, E. & Jané, F. Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose. Eur J Drug Metab Pharmacokinet 16, 269-273 (1991).
26. Lee, J. Y., Kim, Y. H. & Koh, J. Y. Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci 21, RC171 (2001).
27. Desagher, S., Glowinski, J. & Prémont, J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 17, 9060-9067 (1997).
28. Pan, R. et al. Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain. Pediatr Res 72, 479-489 (2012).
29. Maus, M., Marin P., Israël, M., Glowinski, J. & Prémont J. Pyruvate and lactate protect striatal neurons against N-methyl-Daspartate- induced neurotoxicity. Eur J Neurosci 11, 3215-3224 (1999).
30. Izumi, Y. & Zorumski, C. F. Neuroprotective effects of pyruvate following NMDA-mediated excitotoxic insults in hippocampal slices. Neurosci Lett 478, 131-135 (2010).
31. Montgomery, C. M. & Webb, J. L. Metabolic studies on heart mitochondria. I. The operation of the normal tricarboxylic acid cycle in the oxidation of pyruvate. J Biol Chem 221 347-357 (1956).
32. Vonkorff, R. W. Pyruvate-C14, Purity and Stability. Anal Biochem 171-178 (1964).
33. Dirnagl, U., Iadecola, C. & Moskowitz, M. A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391-397 (1999).
34. Chen, J. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688 (2001).
35. Rakhunde, P. B., Saher, S. & Ali, S. A. Neuroprotective effect of Feronia limonia on ischemia reperfusion induced brain injury in rats. Indian J Pharmacol 46, 617-621 (2014).
36. Lee, H. K. et al. Anti-inflammatory effects of OBA-09, a salicylic acid/pyruvate ester, in the postischemic brain. Brain Res 1528, 68-79 (2013).
37. Kim, S. W., Lee, H. K., Kim, H. J., Yoon, S. H. & Lee, J. K. Neuroprotective effect of ethyl pyruvate against Zn2+ toxicity via NAD replenishment and direct Zn2+ chelation. Neuropharmacology 105, 411-419 (2016).
38. Szabó, C., Zingarelli, B., O'Connor, M. & Salzman, A. L. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93, 1753-1758 (1996).